ICON plc | Clinical Research Organisation (CRO) for Drug Development

Glycomics: the future "sweet spot" in precision medicine diagnostics

The rise of glycan biomarkers in therapeutic development.

Parallel consultation from regulators and HTA bodies in Europe

Opportunities and challenges for drug developers.

Antimicrobial resistance

How clinical research can combat an ensuing global crisis.

The evolution of HIV treatments

From antiretroviral therapy to vaccines, where we are today and what’s next.

Webinars

Upcoming webinar: Antimicrobial resistance

24 August, 2021. Register now.

Upcoming webinar: Cell and gene therapies - Development, commercialisation, and planning for the future

25 August, 2021. Register now.

Upcoming webinar: How to increase engagement with medical and scientific posters

25 August, 2021. Register now.

On-demand webinars

Visit our webinar channel to access other recent webinars.

Featured Services

Market Access

Expertise in mission-critical pricing, market access, and reimbursement.

Site & Patient Solutions

Transforming recruitment through patient-centric trials and real-world, real-time data.

Biotech

ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.

Functional Resourcing

From recruitment of a single clinical professional to managing entire global functions.

Increasing Site and Patient Compliance

FIRECREST: Digital solutions to increase efficiency in clinical trials by driving site performance.

ICON Insights

28 June 2021

Legacy devices under MDR/IVDR: a path forward

Regulations from 2017 set stricter requirements on manufacturers product development, data reporting, and quality assurance in place.

23 June 2021

Health Technology Assessment: informal deal between council and European Parliament

In June 2021, representatives of the European Parliament and the Council of European Union reached an agreement to boost cooperation amongst EU member States on HTA.

22 June 2021

Leveraging in-home services for Parkinson’s Disease

New technologies like wearables and mobile devices, in-home services, and increased patient engagement can change the way we treat Parkinson's disease.

21 June 2021

MDR & IVDR bottlenecks: Challenges persist despite deadlines

The new In Vitro Diagnostics Regulation (IVDR) and Medical Device Regulation (MDR) provide regulatory frameworks and conformity assessments that promote medical device safety and efficacy.

11 June 2021

How to improve participation of asymptomatic patients in neurodegenerative disease registries

Insight into the power of patient-registries and how they can be used to increase participation of neurodegenerative patients.

18 May 2021

New procedures for drug prices negotiations and reimbursement in Italy

In March 2021 the Italian Medicines Agency adopted new guidelines for drug pricing and reimbursement decisions.

14 May 2021

10 lessons learned about secondary “real world” data strategy

Insights and lessons learned about operationalizing the use of real world data.

10 May 2021

Managed access programs as an alternative to long-term follow up studies

Managed Access Programs (MAPs), are one solution for early access to investigational products that are gaining traction.

26 April 2021

The data revolution: Big data’s role in clinical trial patient recruitment, retention and engagement

How big data can be leveraged by pharma to solve key challenges in patient recruitment and drug development.

Services

Sectors

Therapeutics

Innovation

Insights

News & Events

About ICON

Medical communications in early phase product development

The affordability hurdle for gene therapies

Closing the evidence gap

Practical considerations for decentralised & hybrid clinical trials